Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience - PNC

Skip to content

UNIPD
DEPARTMENTS
LIBRARIES

WEBMAIL

CONTACT US

WEBMAIL

CONTACT US

Main Menu

ABOUT US
RESEARCH
PHD IN NEUROSCIENCE
NEWS & EVENTS
WORK WITH US

Flyout Menu

Home
About Us
Research
PhD in Neuroscience
News & Events
Work with us
Contact Us

Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience

Home » Publications » Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience

About Us
Research
PHD in Neuroscience

News & Events
Work with us
Contact us

Privacy Policy
Cookie Policy
Transparent Administration

© 2025 Università di Padova - Tutti i diritti riservati

Credits